Acute motor axonal neuropathy in Ecuador: a retrospective case series with electrophysiological and functional correlation
DOI:
https://doi.org/10.69639/arandu.v12i3.1340Palabras clave:
Guillain–Barré Syndrome, AMAN, acute flaccid paralysis, axonal neuropathy, neurophysiologyResumen
Acute Motor Axonal Neuropathy (AMAN) is a severe Guillain–Barré Syndrome (GBS) variant characterized by acute flaccid paralysis and pure motor axonal involvement. In Latin America, its diagnosis remains challenging due to limited access to neurophysiological tools. This case series describes three Ecuadorian male patients diagnosed with AMAN between 2017 and 2025, each with recent gastrointestinal infection. Electromyography confirmed axonal motor neuropathy in all cases. One patient, a high-performance cyclist, required mechanical ventilation and fully recovered after IVIG. Another, a retired officer, showed partial improvement and remains orthotic-dependent. The third, a former conscript, developed irreversible quadriplegia despite treatment and prolonged ICU stay. Antiganglioside antibodies were tested in one case, revealing GD1a, GD1b, and GT1b positivity. These cases demonstrate the clinical heterogeneity of AMAN and the importance of early diagnosis, timely immunotherapy, and structured rehabilitation. Increased awareness and improved diagnostic capacity are essential to optimize outcomes in AMAN patients in resource-limited settings.
Descargas
Citas
Jacobs, B. C., Rothbarth, P. H., van der Meché, F. G. A., Herbrink, P., Schmitz, P. I. M., de Klerk, M. A., & van Doorn, P. A. (1998). The spectrum of antecedent infections in Guillain–Barré syndrome: A case-control study. Neurology, 51(4), 1110–1115. https://doi.org/10.1212/WNL.51.4.1110
Kuwabara, S., & Yuki, N. (2013). Axonal Guillain–Barré syndrome: Concepts and controversies. The Lancet Neurology, 12(12), 1180–1188. https://doi.org/10.1016/S1474-4422(13)70215-1
McGrogan, A., Madle, G. C., Seaman, H. E., & de Vries, C. S. (2009). The epidemiology of Guillain–Barré syndrome worldwide: A systematic literature review. Neuroepidemiology, 32(2), 150–163. https://doi.org/10.1159/000184748
Patone, M., Handunnetthi, L., Saatci, D., Pan, J., Katikireddi, S. V., Razvi, S., ... & Hippisley-Cox, J. (2021). Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nature Medicine, 27(12), 2144–2153. https://doi.org/10.1038/s41591-021-01556-7
Sejvar, J. J., Baughman, A. L., Wise, M., & Morgan, O. W. (2011). Population incidence of Guillain–Barré syndrome: A systematic review and meta-analysis. Neuroepidemiology, 36(2), 123–133. https://doi.org/10.1159/000324710
Susuki, K., Yuki, N., Schafer, D. P., Hirata, K., Zhang, G., Funakoshi, K., ... & Rasband, M. N. (2007). Dysfunction of nodes of Ranvier: A mechanism for anti-ganglioside antibody-mediated neuropathies. Experimental Neurology, 206(2), 244–252. https://doi.org/10.1016/j.expneurol.2007.05.030
Uncini, A., & Kuwabara, S. (2018). The electrodiagnosis of Guillain–Barré syndrome subtypes: Where do we stand? Clinical Neurophysiology, 129(12), 2586–2593. https://doi.org/10.1016/j.clinph.2018.08.034
Van den Berg, B., Walgaard, C., Drenthen, J., Fokke, C., Jacobs, B. C., & van Doorn, P. A. (2014). Guillain–Barré syndrome: Pathogenesis, diagnosis, treatment and prognosis. Nature Reviews Neurology, 10(8), 469–482. https://doi.org/10.1038/nrneurol.2014.121
Willison, H. J., Jacobs, B. C., & van Doorn, P. A. (2016). Guillain–Barré syndrome. The Lancet, 388(10045), 717–727. https://doi.org/10.1016/S0140-6736(16)00339-1
Yuki, N., & Hartung, H. P. (2012). Guillain-Barré syndrome. The New England Journal of Medicine, 366(24), 2294–2304. https://doi.org/10.1056/NEJMra1114525
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2025 Ana Karina Pérez León, Hugo Esteban Salazar Lozano, María Daniela Pérez León, Andrea Carolina Pérez León, Diego Fernando Atapuma Madrid
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Esta publicación está bajo una 
